IGC Pharma IGC Cash Flow Statement (2010-2025)

NYSE IGC
$0.28 +0.00 (+1.19%)
As of: Sep 10, 2026 · 3:23 PM EDT
Reported Financials

IGC Pharma Quarterly Cash Flow Statement

Periods 62 quarters
Latest Sep 2025

IGC Pharma reported cash from operations of -$1.36M and free cash flow of -$1.37M for the quarter ended Sep 2025, down 36.5% year over year. This cash flow statement covers 62 quarters of results from Jun 2010 through Sep 2025, standardized by Business Quant from the company’s SEC filings.

Cash Flow Statement Jun2010 Sep2010 Dec2010 Mar2011 Jun2011 Sep2011 Dec2011 Mar2012 Jun2012 Sep2012 Dec2012 Mar2013 Jun2013 Sep2013 Dec2013 Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Operating Activities
Net Income
-2.32M-1.10M-1.79M-4.34M-2.38M-3.35M-2.79M-2.44M-2.25M-1.61M-2.08M-2.45M-5.59M-0.15M-2.38M-1.72M-1.83M-1.20M-2.80M-1.82M
Share-based CompensationStock Comp.
0.16M0.14M0.12M0.42M0.52M1.12M1.15M0.62M0.48M0.58M0.36M0.55M0.53M0.34M0.40M0.40M3.50M0.46M4.70M3.79M
Deferred Taxes
Asset Writedowns and ImpairmentWritedown
0.17M0.04M0.13M0.09M0.15M0.15M
Cash from OperationsCash from Ops.
-1.84M-2.50M-1.85M-2.30M-2.42M-0.89M-2.20M-1.69M-1.65M-1.52M-1.47M-1.62M-1.59M-0.53M-1.75M-1.00M-1.32M-0.73M-2.14M-1.36M
Depreciation, Depletion & Amortization
Amortizatization of IntangiblesAmort. of Intangibles
0.00M0.00M0.03M0.03M0.03M0.04M0.03M0.03M
Amortization of Deferred ChargesAmort. Deferred Charges
Depreciation & Amortization (CF)Dep. & Amort.
0.13M0.17M0.16M0.16M0.17M0.17M0.16M0.17M0.17M0.15M0.15M0.16M0.16M0.16M0.16M0.14M0.16M0.15M0.29M-0.04M
Change in Working Capital
Change in ReceivablesChange Receivables
-0.04M-0.05M-0.01M-0.02M0.03M-0.04M0.02M0.04M0.06M-0.13M0.12M-0.09M-0.04M0.04M-0.01M0.02M0.01M-0.00M0.05M-0.04M
Change in InventoryChange Inventory
-1.53M0.32M-0.00M0.02M-0.07M-1.88M0.07M0.13M-0.00M-1.10M-0.01M-0.01M0.02M-1.02M-0.03M-0.08M-0.07M-0.08M0.07M
Change in Account PayablesChange Payables
-0.11M0.77M0.09M-0.15M-0.61M1.17M-0.52M-0.01M0.02M0.07M0.14M-0.12M0.10M0.13M-0.00M-0.00M0.07M0.04M0.10M-0.35M
Change in Accured ExpensesChange Accured Exp.
0.03M-0.03M-0.03M0.48M0.09M0.09M-0.27M0.28M0.15M0.32M-0.22M-0.45M-1.05M0.54M
Investing Activities
Capital ExpendituresCapex
0.15M0.09M0.09M0.03M0.03M0.08M0.13M-0.40M0.58M0.01M0.02M0.04M0.07M0.01M0.04M0.03M0.03M0.02M0.03M0.01M
Sales of Property, Plant and EquipmentPP&E (Sale)
0.54M-0.01M0.04M-0.00M0.00M0.02M0.02M0.73M-0.05M
Acquisitions
Change in Acquisitions & DivestmentsChange Acquisitions
1.85M-3.03M
Cash from Investing ActivitiesCash from Investing
1.65M1.93M-0.10M-0.04M-0.05M-0.55M-0.16M0.18M-0.02M-0.24M-0.01M0.07M-0.06M-0.32M-0.13M-0.07M-0.10M-0.14M0.58M-0.23M
Financing Activities
Other financing activitiesOther financing
3.00M
Cash from Financing ActivitiesCash from Financing
14.16M0.73M3.42M-0.00M-0.00M-0.00M0.10M-0.00M-0.00M2.86M-0.00M0.67M2.51M0.79M0.34M0.81M1.66M2.31M
Change in Capital Stock
Net Shares Issued and RepurchasedNet Shares Issued
Net Equity Issued and RepurchasedNet Equity Issued
14.16M0.73M3.42M0.10M2.86M0.17M2.51M0.80M0.35M0.81M1.66M2.31M
Dividend Payments
Dividends Paid - CommonDiv. Paid (Common)
Additional items
Exchange Rate EffectFX Effect
0.01M-0.00M-0.01M0.01M0.01M-0.04M-0.05M-0.03M-0.01M0.01M0.00M-0.01M0.00M0.00M0.00M-0.01M0.00M0.03M0.00M
Change in Cash
-0.18M13.58M-1.23M1.08M-2.46M-1.48M-2.41M-1.43M-1.68M-1.75M-1.47M1.30M-1.65M-0.18M0.63M-0.28M-1.08M-0.07M0.05M0.72M
Free Cash FlowFCF
-2.00M-2.59M-1.94M-2.33M-2.45M-0.97M-2.32M-1.28M-2.23M-1.52M-1.49M-1.65M-1.66M-0.54M-1.79M-1.02M-1.34M-0.75M-2.16M-1.37M
Net Cash FlowNCF
-0.19M13.58M-1.22M1.07M-2.47M-1.44M-2.35M-1.40M-1.67M-1.76M-1.47M1.31M-1.65M-0.18M0.62M-0.27M-1.08M-0.07M0.10M0.71M